LEP and obesity disorder: Metabolic abnormalities within adipose tissue can contribute to obesity complications including excess adipokine secretion: visfatin, leptin, and resistin, but also TNF-α as and plasminogen activator inhibitor-1 (PAI-1) [28–31].